PharmaLex
PharmaLex (Cencora PharmaLex) is a Germany-based specialized consulting and technology firm providing regulatory affairs, pharmacovigilance, clinical development, and market access services to 1,600+ pharma, biotech, and medtech clients across 32 countries, operating as a subsidiary of Cencora Inc.
- Company typePrivate
- Founded1998
- HeadquartersFriedrichsdorf, Germany
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What PharmaLex does
PharmaLex (now operating as Cencora PharmaLex) is a Germany-headquartered specialized services provider for the pharmaceutical, biotech, and medtech industries, operating as a wholly-owned subsidiary of Cencora Inc. (formerly AmerisourceBergen, NYSE: ABC) since January 2023. The company delivers end-to-end consulting and technology-enabled services across regulatory affairs and CMC, pharmacovigilance and patient safety, clinical development and biostatistics, market access and HEOR, quality management and compliance, and research and development. Service delivery is executed through 60+ offices in 32 countries via multi-year Statements of Work, serving 1,600+ clients including 9 of the 10 top global pharmaceutical companies.
The company operates a dual model combining professional services with a proprietary SaaS portfolio of 14+ products under the SMART brand, alongside PhlexTMF (AI-powered electronic Trial Master File system), psiXchange (safety document distribution automation), and the psi application suite built on Oracle APEX. The technology stack integrates with major safety and clinical trial systems (ArisG LifeSphere, Oracle Argus, AB Cube Safety Easy, CTMS), and the SMART products are GAMP5 validated and 21 CFR Part 11 compliant for regulated use. AI is applied selectively in document classification (PhlexTMF) and literature screening (SMARTVIGILIT), and the platform is twice-nominated by CPhI for innovative technology use.
The business operates a B2B consulting model with project-based SOW engagements, monthly invoicing, and 14-30 day payment terms, supplemented by subscription-based SaaS revenue from its proprietary technology. The company goes to market via direct enterprise sales with regional managing directors and business development managers covering territories including UK/Ireland/Nordics, the US, and other regions. Cross-sell is now enabled through Cencora's distribution and manufacturer relationships. PharmaLex has pursued an aggressive M&A strategy (20+ acquisitions since 2017) to build out geographic, service-line, and technology capabilities.
PharmaLex firmographics
Firmographics- Name
- PharmaLex
- Legal name
- PharmaLex GmbH
- Website
- https://pharmalex.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- PharmaLex (Cencora PharmaLex) is a Germany-based specialized consulting and technology firm providing regulatory affairs, pharmacovigilance, clinical development, and market access services to 1,600+ pharma, biotech, and medtech clients across 32 countries, operating as a subsidiary of Cencora Inc.
- Ownership category
- akta.pro rank
PharmaLex industry classification
Industry- Product category
- Pharmaceutical Regulatory Consulting
- NAICS
- Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)
- akta.pro secondary industries
- Pharmacovigilance & Drug Safety Software (HLAGAJAK), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where PharmaLex is headquartered
LocationHeadquarters
- HQ city
- Friedrichsdorf
- HQ country
- Germany
- HQ region
- Europe
Offices11 records
Markets served
PharmaLex business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others
Revenue model
- Regulatory Affairs and CMC Consulting: Fees for regulatory strategy, submissions, agency interactions, eCTD management, CMC services, and post-approval maintenance consulting engagements. Delivered via SOW-based project engagements.
- Pharmacovigilance / Patient Safety Services: Fees for adverse event processing, signal detection, literature surveillance, QPPV services, PV audits, and local affiliate PV services. Typically project-based or retainer engagements.
- Clinical Development and Statistics Services: Fees for clinical development consulting, biostatistics, CMC statistics, data science, discovery statistics, and omics data science services.
- Market Access and HEOR Services: Fees for health economics and outcomes research, pricing and reimbursement strategy, and market access consulting.
- SaaS / Technology-Enabled Services: Revenue from proprietary software platforms including psiXchange, PhlexTMF, SmartStats, and other SaaS tools. Implied to be subscription or usage-based licensing.
- Quality Management and Compliance Services: Fees for quality management, compliance audits, GMP/GDP compliance, and regulatory consulting services.
- Training Services: Fees for training courses delivered through PharmaLex's dedicated training platform (learn.pharmalex.com).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Enterprise Consulting Engagements |
| Other | Multi-year contract | Project-Based Engagements |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels8 records
PharmaLex product offering
Product offeringCore offering
PharmaLex provides specialized consulting services to pharmaceutical, biotech, and medical device companies across the full product lifecycle, including regulatory affairs and CMC, pharmacovigilance/patient safety, clinical development and biostatistics, market access and HEOR, and quality management and compliance. The company complements these professional services with proprietary SaaS platforms (PhlexTMF, psiXchange, SmartStats, and the SMART suite) that automate safety document distribution, trial master file management, statistical reporting, and regulatory intelligence. Engagements are delivered through SOW-based consulting and subscription/usage-based software licensing to more than 1,600 clients globally.
Product overview
PharmaLex offers a comprehensive platform of specialized services and technology solutions for the pharmaceutical, biotech, and medical device industries. The portfolio includes both professional consulting services across regulatory affairs, pharmacovigilance, market access, statistics and data science, and research and development, as well as a suite of SMART-branded SaaS software products (SMARTDECISIONS, SMARTTRACE, SMARTAUTOMATE, SMARTCHECK, SMARTCHECK MDR, SMARTVIGISCREEN, SMARTVIGICONTRACT, SMARTVIGILIT, SMARTRISK, SMARTENOVAL, SMARTSTABELITY, SMARTSEELVA, SMARTTRANSVAL, SmartStats) designed to improve compliance, speed to market, and quality. Additionally, the company offers specialized technology platforms including PhlexTMF (AI-powered eTMF system), psiXchange (safety document distribution automation), and the psi application suite (psiQ, psiXchange, psiCentral, psiMigration, psiMonitor) developed on Oracle APEX. These products work together to support clients from early strategic planning through clinical development, regulatory submission, and post-approval maintenance across the entire product lifecycle.
Differentiator
Problem solved
Functional benefit
Brands
- PhlexTMF: AI-Powered TMF Document Submission and Classification SaaS offering with electronic Trial Master File system
- psiXchange
- SmartStats
- SmartDecisions
- SmartTrace
- SmartAutomate
- SmartCheck
- SmartVigiScreen
- SmartVigiContract
- SmartVigiLit
- SmartRisk
- SmartEnoval
- SmartStabelity
- SmartSeelva
- SmartTransVal
Products and services
- PhlexTMF AI-powered Electronic Trial Master File (eTMF) system pre-trained on millions of TMF documents. Provides instant AI-driven classification suggestions after document upload to ensure clinical documents are right-first-time, reducing misfiles and metadata errors. Embeds cumulative guidance of hundreds of TMF experts and improves TMF quality, lowers inspection risk, and prevents time-consuming remediation. GAMP5 validated and 21 CFR Part 11 compliant.
- psiXchange Centralized regulatory intelligence platform that entirely automates the complex distribution process for critical safety documents. Allows sending of any business-critical safety document to any recipient and seamlessly connects to data sources including ArisG LifeSphere, Oracle Argus, and AB Cube Safety Easy. Achieved up to 90% reduction in resource requirements and 95% site response rate.
- SmartStats Comprehensive automated statistical report writing software with multiple modules that facilitate report generation in line with EMA, FDA, and MHLW guidelines. Standardizes reporting across organizations, is GAMP5 validated and 21 CFR Part 11 compliant, and significantly reduces human errors in statistical reporting.
- SmartDecisions Regulatory Intelligence system for managing officially published Health Authority guidelines, combined with PharmaLex's own experience and recommended best practices.
- SmartTrace Regulatory Information and Process Management system for managing the workflow of regulatory submissions from the planning phase through to submission and archive.
- SmartAutomate Microsoft Word plug-in tool for automating selected existing document processing functionality within regulatory and safety workflows.
- SmartCheck Intelligent system to support the maintenance of medical product information such as packaging and patient leaflets.
- SmartCheck MDR Smart tool that assesses a medical device company's readiness and determines their state of compliance for the EU Medical Device Regulation (effective May 2021).
- SmartVigiScreen Application for processing and screening case safety reports of adverse reactions to medicinal products.
- SmartVigiContract Database that tracks pharmacovigilance agreements between clients and third parties.
- SmartVigiLit Web-based solution for global and local literature monitoring and screening in pharmacovigilance.
- SmartRisk Management system for data related to the use of excipients (inactive ingredients) in the manufacturing of medicinal products.
- SmartEnoval Software for the validation of physicochemical methods such as LC, GC, EC, AAS, titration, and UV.
- SmartStabelity Software dedicated to the evaluation of the long-term stability of products and the determination of shelf life.
- SmartSeelva Software dedicated to the validation of bioassays such as ELISA, RIA, parallel line, parallel curve, slope-ratio, microbiological assays, and qPCR.
- SmartTransVal Software dedicated to assessing if an analytical method can be transferred from a sender lab to one or several receiver labs according to the tolerance interval approach.
- Regulatory Affairs and CMC Services Professional consulting services for pharmaceutical, biotech, and consumer health companies covering agency interactions, CMC biologics, CMC services, eCTD system operations and data management, post-approval maintenance, promotional materials and compliance, and regulatory/scientific writing.
- Patient Safety (Pharmacovigilance) Services Professional pharmacovigilance services including clinical trials adverse event processing, gap analysis and consulting, ICSR management, literature surveillance, local affiliate pharmacovigilance services, monitoring and signal detection, pharmacovigilance audits, and Qualified Person for Pharmacovigilance (QPPV).
- Research and Development Services Consulting services including Clinical Development Services, Clinical Trial Applications, Development Strategy, and Toxicological Services and Risk Assessment for pharma and biotech clients.
- Statistics and Data Science Services Professional services including Clinical Biostatistics, CMC Statistics, Data Strategy and Data Governance, Discovery Statistics, and Omics Data Science.
- Market Access Services Professional services including Health Economics and Outcomes Research (HEOR), Market Access Strategy, and Pricing and Reimbursement consulting for pharma and biotech clients.
- Quality Management and Compliance Services Professional services for quality management, GMP/GDP compliance audits, and regulatory consulting in life sciences.
- PharmaLex Training Services Specialized training courses delivered through PharmaLex's dedicated training platform (learn.pharmalex.com), covering regulatory affairs, pharmacovigilance, CMC, market access, and related life sciences topics.
Quantifiable outcome
- Up to 90% reduction in resource requirements for safety document distribution through Oracle APEX/psiXchange implementation
- +4 more outcomes
Companies that use PharmaLex
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles4 records
PharmaLex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability3 records
Feature13 records
PharmaLex partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- NeoHealthHubminorPharmaLex announced merger with UK-based NeoHealthHub to strengthen its specialised services presence. This merger expanded PharmaLex's capabilities in the UK market.
- EBMA ConsultingcorePharmaLex merged with Italy-based EBMA Consulting in March 2022. EBMA is a specialist consultancy focused on strategic pricing, market access, and health economics services. Founded in 2010 by Gianluca Furneri, it serves small and mid-sized pharmaceutical companies in Italy, Europe, and the US.
- PhlexglobalcorePharmaLex Group announced a merger with Phlexglobal in January 2022. Phlexglobal provides the PhlexTMF electronic Trial Master File system, which is pre-trained on millions of TMF documents with embedded guidance from hundreds of TMF experts.
- MAP Group (Italy)corePharmaLex merged with MAP Group (Italy's leading provider of market access services) in January 2022. MAP Group comprises three companies: MA Provider, MAPCOM Consulting, and 3P Solution, delivering market access, communication, and educational services. Staff of more than 70 experts. Specializes in ATMPs for rare diseases and oncology.
- OraclecorePharmaLex implemented Oracle Cloud and Oracle APEX to power its psiXchange SaaS platform for safety document distribution. The implementation achieved 90% reduction in resource requirements and 95% site response rate. Oracle APEX enabled development of the complete PharmaLex application suite including psiQ, psiXchange, psiCentral, psiMigration, and psiMonitor with optimized CI/CD deployment across multiple environments.
- ATMP ForumminorMAP Group (acquired by PharmaLex) is a leading member of ATMP Forum, a virtual organization established in 2017 to allow stakeholders to discuss issues related to Advanced Therapy Medicinal Product (ATMP) development.
Scale indicators8 records
Recent moves7 records
Expansion highlights5 records
PharmaLex competitors and assessment
Company assessmentEmerging players
- ProPharma Group: ProPharma Group is a regulatory compliance, pharmacovigilance, and quality consulting firm serving pharma, biotech, and medical device companies. It directly overlaps with PharmaLex's GxP compliance, PV, and regulatory services.
- Voisin Consulting Life Sciences (VCLS): VCLS is a specialized regulatory, market access, and HEOR consulting firm serving biotech and medtech companies. It competes with PharmaLex particularly in EU regulatory strategy and market access for innovative therapies.
Direct peers
- IQVIA: IQVIA is the world's largest CRO and healthcare data analytics firm, offering regulatory affairs, pharmacovigilance, clinical development, and technology-enabled services directly competing with PharmaLex across most service lines, particularly for top-10 pharma accounts.
- Parexel International: Parexel is a leading global CRO with deep regulatory consulting, clinical development, and pharmacovigilance services. It directly competes with PharmaLex for biotech and pharma regulatory/PV outsourcing engagements.
- ICON plc: ICON is a top global CRO offering clinical, regulatory, and laboratory services. After PRA Health Sciences acquisition, ICON has strengthened its regulatory and biostatistics capabilities that overlap directly with PharmaLex's portfolio.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size global CRO offering clinical development, biostatistics, and regulatory services. It competes with PharmaLex for biotech and mid-cap pharma regulatory and clinical development engagements.
- Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical development, regulatory affairs, and commercialization services, competing with PharmaLex in regulatory and clinical development outsourcing.
Broad incumbents
- Labcorp Drug Development (now Fortrea): Fortrea (spun out of Labcorp in 2023) is a major CRO providing clinical development and central laboratory services. Its regulatory and pharmacovigilance services compete with PharmaLex, particularly for global pharma clients.
- Charles River Laboratories: Charles River is a large non-clinical CRO and manufacturing services provider with broader lab services, but its regulatory and safety consulting divisions overlap with PharmaLex's CMC and regulatory affairs offerings.
Others
- Skillpad (Pharma Lesson): Skillpad is a provider of pharmaceutical training and GxP e-learning solutions serving the same life sciences customer base as PharmaLex's training services division (learn.pharmalex.com).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
PharmaLex social profiles
Digital presencePharmaLex compliance and trust
Trust signalCompliance2 records
PharmaLex financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmaLex leadership team
Management profileNumber of profiles
Profiles18 records
PharmaLex subsidiaries and ownership
Company hierarchySubsidiaries5 records
PharmaLex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmaLex M&A and investment
M&A and investmentM&A23 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmaLex
What does PharmaLex do?
PharmaLex provides specialized consulting services to pharmaceutical, biotech, and medical device companies across the full product lifecycle, including regulatory affairs and CMC, pharmacovigilance/patient safety, clinical development and biostatistics, market access and HEOR, and quality management and compliance. The company complements these professional services with proprietary SaaS platforms (PhlexTMF, psiXchange, SmartStats, and the SMART suite) that automate safety document distribution, trial master file management, statistical reporting, and regulatory intelligence. Engagements are delivered through SOW-based consulting and subscription/usage-based software licensing to more than 1,600 clients globally.
Is PharmaLex a public or private company?
PharmaLex is a private company. It is classified as corporate owned and is currently operating.
When was PharmaLex founded?
PharmaLex was founded in 1998. It employs 1,001 to 5,000 people.
Where is PharmaLex based?
PharmaLex is headquartered in Friedrichsdorf, Germany, in the Europe region.
How does PharmaLex make money?
Seven revenue lines are on record. Regulatory Affairs and CMC Consulting is the primary driver. The others are pharmacovigilance / Patient Safety Services, clinical Development and Statistics Services, market Access and HEOR Services, saaS / Technology-Enabled Services, quality Management and Compliance Services and training Services.
Who are PharmaLex's main competitors?
Emerging players on record are ProPharma Group and Voisin Consulting Life Sciences (VCLS). Direct peers are IQVIA, Parexel International, ICON plc, Worldwide Clinical Trials and Syneos Health. Broad incumbents are Labcorp Drug Development (now Fortrea) and Charles River Laboratories. Skillpad (Pharma Lesson) is listed as an others.
Does PharmaLex have an API?
Yes. PharmaLex offers technology solutions including psiXchange SaaS platform that integrates with various systems. The Oracle APEX implementation achieved optimized CI/CD deployment across multiple environments. While no public API documentation is explicitly mentioned, the platform's integration capabilities with systems like ArisG LifeSphere, Oracle Argus, and AB Cube Safety Easy suggest backend API connectivity for enterprise customers.
What industry is PharmaLex in?
PharmaLex's product category is Pharmaceutical Regulatory Consulting. Its primary akta.pro industry code is HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA), with a secondary code of HLAGAJAK, Pharmacovigilance & Drug Safety Software. Its NAICS code is 54161 and its SIC code is 8742.